These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 751903)

  • 1. Cellular immunity in infectious mononucleosis: I. Spontaneous and phytohaemagglutinin-induced blast transformation in infectious mononucleosis, with special reference to depressed cellular reactivity and stimulation-blocking serum factors.
    Nikoskelainen J; Stevens DA; Neel EU; Isenberg RA; Miller RG; Halpern JW; Gelpi AP
    IARC Sci Publ (1971); 1978; (24 Pt 2):699-709. PubMed ID: 751903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
    J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P; Levine PH; Ablashi DV; Royston I
    Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte reactivity in infectious mononucleosis.
    ten Napel CH; The TH
    J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
    J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG from Epstein-Barr virus infectious mononucleosis patients inhibits interleukin-2 production.
    Sundar SK; Stefanescu I; Menezes J
    Int J Immunopharmacol; 1987; 9(8):869-73. PubMed ID: 3501412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of spontaneous in vitro transformation of autologous leukocytes by plasma from convalescent and postconvalescent infectious mononucleosis patients.
    Chang RS; Spina CA
    J Natl Cancer Inst; 1975 Oct; 55(4):803-5. PubMed ID: 171425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infectious mononucleosis].
    Yoneyama A
    Rinsho Byori; 2001 Oct; 49(10):996-9. PubMed ID: 11769479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection].
    Konno M
    Hokkaido Igaku Zasshi; 1989 Mar; 64(2):125-38. PubMed ID: 2543617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J
    Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypical, functional and chromosomal studies of lymphocytes from patients with infectious mononucleosis.
    Jensen JR; Bisballe S; Pedersen EB; Christensen KD; Thestrup-Pedersen K
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):9-14. PubMed ID: 6603097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.